Cancer drug prices slashed in India
The story in brief
The NPPA cut prices of 543 cancer drugs, including biosimilars and monoclonal antibodies, by up to 90%. Oncologists in Kolkata noted that high out-of-pocket costs push families into financial ruin and force treatment dropouts. Bevaceril 400 prices fell from Rs 75,718 to Rs 12,668.